New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Alcohol linked to higher risk across multiple cancers, even below one drink daily

Alcohol linked to higher risk across multiple cancers, even below one drink daily

byInstitute for Health Metrics and EvaluationCredit: Pixabay from PexelsA new study from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington provides the most compre
Hematology&Oncology August 19,2026
Alcohol linked to higher risk across multiple cancers, even below one drink daily

Alcohol linked to higher risk across multiple cancers, even below one drink daily

byInstitute for Health Metrics and EvaluationCredit: Pixabay from PexelsA new study from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington provides the most compre
Hematology&Oncology August 19,2026
Blood test spots 14 proteins that predict lung cancer risk up to five years early

Blood test spots 14 proteins that predict lung cancer risk up to five years early

byThe Francis Crick InstituteGraphical abstract. Credit:Cell(2026). DOI: 10.1016/j.cell.2026.05.005As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start
Hematology&Oncology August 19,2026
Blood test spots 14 proteins that predict lung cancer risk up to five years early

Blood test spots 14 proteins that predict lung cancer risk up to five years early

byThe Francis Crick InstituteGraphical abstract. Credit:Cell(2026). DOI: 10.1016/j.cell.2026.05.005As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start
Hematology&Oncology August 19,2026
Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

by Christopher Lieu,The ConversationKRAS (blue) has been difficult for drugs to target. Credit:Fvasconcellos/Wikimedia CommonsFor a long time, the likelihood of surviving pancreatic cancer has been ex
Hematology&Oncology August 19,2026
Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

by Christopher Lieu,The ConversationKRAS (blue) has been difficult for drugs to target. Credit:Fvasconcellos/Wikimedia CommonsFor a long time, the likelihood of surviving pancreatic cancer has been ex
Hematology&Oncology August 19,2026
New breakthrough in developing more personalized treatments for lung cancer

New breakthrough in developing more personalized treatments for lung cancer

byUniversity of BarcelonaSummary of the major findings of this study on the histotype-dependent patterns of SMAD2/3 signaling and their relation with angiogenesis/hypoxia regulation in lung TAFs. Cred
Hematology&Oncology August 19,2026
New breakthrough in developing more personalized treatments for lung cancer

New breakthrough in developing more personalized treatments for lung cancer

byUniversity of BarcelonaSummary of the major findings of this study on the histotype-dependent patterns of SMAD2/3 signaling and their relation with angiogenesis/hypoxia regulation in lung TAFs. Cred
Hematology&Oncology August 19,2026
Creatine may supercharge immune cells that are key to fighting cancer

Creatine may supercharge immune cells that are key to fighting cancer

by Tiare Dunlap,University of California, Los AngelesAn artistic rendering of a human dendritic cell. Credit: Don Bliss & Sriram Subramaniam, National Cancer InstituteCreatine, the organic acid th
Hematology&Oncology August 19,2026
Creatine may supercharge immune cells that are key to fighting cancer

Creatine may supercharge immune cells that are key to fighting cancer

by Tiare Dunlap,University of California, Los AngelesAn artistic rendering of a human dendritic cell. Credit: Don Bliss & Sriram Subramaniam, National Cancer InstituteCreatine, the organic acid th
Hematology&Oncology August 19,2026
Colorectal cancer has a backup plan, and it begins when mature gut cells regain stem-like traits

Colorectal cancer has a backup plan, and it begins when mature gut cells regain stem-like traits

byStevens Institute of TechnologyACD44 immunoreactivity in the double mutant villi epithelium (arrows), suggesting oncogenic stemness in the 7-day double mutant (DM) villin= 3.Bleft panel: Schema for
Hematology&Oncology August 18,2026
Colorectal cancer has a backup plan, and it begins when mature gut cells regain stem-like traits

Colorectal cancer has a backup plan, and it begins when mature gut cells regain stem-like traits

byStevens Institute of TechnologyACD44 immunoreactivity in the double mutant villi epithelium (arrows), suggesting oncogenic stemness in the 7-day double mutant (DM) villin= 3.Bleft panel: Schema for
Hematology&Oncology August 18,2026
Poop tests and blood tests join colonoscopy as options for colorectal cancer screening

Poop tests and blood tests join colonoscopy as options for colorectal cancer screening

by Andrea Dwyer,The ConversationCredit: Karolina Grabowska from PexelsIt's increasingly common to see headlines and social media conversations about therise in colorectal cancer among younger adul
Hematology&Oncology August 18,2026
Poop tests and blood tests join colonoscopy as options for colorectal cancer screening

Poop tests and blood tests join colonoscopy as options for colorectal cancer screening

by Andrea Dwyer,The ConversationCredit: Karolina Grabowska from PexelsIt's increasingly common to see headlines and social media conversations about therise in colorectal cancer among younger adul
Hematology&Oncology August 18,2026
TP53 gene mutations affect lung cancer treatment response, study shows

TP53 gene mutations affect lung cancer treatment response, study shows

by Fernanda Bassette,FAPESPCredit: Unsplash/CC0 Public DomainLung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic disease with diff
Hematology&Oncology August 18,2026
TP53 gene mutations affect lung cancer treatment response, study shows

TP53 gene mutations affect lung cancer treatment response, study shows

by Fernanda Bassette,FAPESPCredit: Unsplash/CC0 Public DomainLung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic disease with diff
Hematology&Oncology August 18,2026
Short-term fasting could boost chemo response in ovarian cancer, study suggests

Short-term fasting could boost chemo response in ovarian cancer, study suggests

A simple change in meal timing may help improve outcomes for women with the most common and aggressive form of ovarian cancer, a newstudysuggests.The findings were presented at a meeting of the Americ
Hematology&Oncology August 18,2026
Short-term fasting could boost chemo response in ovarian cancer, study suggests

Short-term fasting could boost chemo response in ovarian cancer, study suggests

A simple change in meal timing may help improve outcomes for women with the most common and aggressive form of ovarian cancer, a newstudysuggests.The findings were presented at a meeting of the Americ
Hematology&Oncology August 18,2026
Study reveals asbestos blind spot in lung cancer screening may cost lives

Study reveals asbestos blind spot in lung cancer screening may cost lives

by Laura Thomas,Curtin UniversityCredit: Sonny Sixteen from PexelsNew Curtin University research has found Australians exposed to asbestos could be falling through the cracks of lung cancer screening
Hematology&Oncology August 18,2026
Study reveals asbestos blind spot in lung cancer screening may cost lives

Study reveals asbestos blind spot in lung cancer screening may cost lives

by Laura Thomas,Curtin UniversityCredit: Sonny Sixteen from PexelsNew Curtin University research has found Australians exposed to asbestos could be falling through the cracks of lung cancer screening
Hematology&Oncology August 18,2026
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com